Nelson Vergel
Founder, ExcelMale.com
Interesting study:
Seeking to explore the relationship between androgens and brain cancer in humans, the researchers analyzed existing clinical data made available through the NIH/NCI Surveillance, Epidemiology, and End Results (SEER) database. They found that men with glioblastoma who were receiving supplemental testosterone for reasons unrelated to cancer demonstrated a 38% lower risk of death compared to patients not taking the same supplements.
Seeking to explore the relationship between androgens and brain cancer in humans, the researchers analyzed existing clinical data made available through the NIH/NCI Surveillance, Epidemiology, and End Results (SEER) database. They found that men with glioblastoma who were receiving supplemental testosterone for reasons unrelated to cancer demonstrated a 38% lower risk of death compared to patients not taking the same supplements.
